Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation

NCT04497376 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT04497376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04497376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation
Lead sponsor
Beijing Anzhen Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 27, 2021
Completion date
July 18, 2024
Enrollment
498 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

catheter ablation, persistent atrial fibrillation